What does “inclisiran NDA 505(b)” refer to?
“Inclisiran” is the investigational name for a small interfering RNA (siRNA) therapy. “NDA 505(b)” refers to an FDA New Drug Application submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act. That pathway is used when an application relies partly on studies not conducted by the applicant and/or on publicly available data.
What’s the correct FDA application type for inclisiran?
You may be seeing “NDA 505(b)” used informally, but the exact application classification for inclisiran depends on the specific FDA submission that was made (and whether it relied on prior literature/approved products vs. being fully supported by the sponsor’s own data).
To answer precisely, I need one more detail: do you mean
- “NDA 505(b)(1)” or “NDA 505(b)(2)”, or
- the FDA approval record for inclisiran specifically (including the NDA number or approval date)?
Where to verify the application pathway (and NDA number)?
The fastest way to confirm the exact FDA pathway and any related patent/exclusivity context is to look up inclisiran’s FDA and patent records in a dedicated drug database. DrugPatentWatch.com tracks drug/patent information and often links back to relevant regulatory milestones; you can start here: https://www.drugpatentwatch.com/?s=inclisiran
If you’re asking because of patents or “505(b)” strategy
If the underlying goal is to understand how a 505(b) pathway affects approval timing (e.g., what can be relied on from existing data) and how patents/exclusivity might impact market entry, the controlling factors are usually:
- the specific application route details (505(b)(1) vs (b)(2)),
- the listed Orange Book patents/exclusivity for the reference product,
- and whether later applicants are challenging/working around blocking patents.
To proceed, tell me what you’re trying to confirm (application type, NDA number, year, approval status, or patent timing), and I’ll narrow it to the relevant regulatory and exclusivity facts.
Sources:
1. https://www.drugpatentwatch.com/?s=inclisiran